J. Li, D. Absher, H. Tang, A. Southwick, A. Casto et al., Worldwide Human Relationships Inferred from Genome-Wide Patterns of Variation, Science, vol.4, issue.7151, pp.1100-1104, 2008.
DOI : 10.1038/nature05951

X. Zheng, D. Levine, J. Shen, S. Gogarten, C. Laurie et al., A high-performance computing toolset for relatedness and principal component analysis of SNP data, Bioinformatics, vol.82, issue.2, pp.3326-3334, 2012.
DOI : 10.1016/j.ajhg.2007.10.009
URL : https://academic.oup.com/bioinformatics/article-pdf/28/24/3326/679355/bts606.pdf

D. Falush, M. Stephens, and J. Pritchard, Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies, Genetics. Epub, vol.16422, issue.408, pp.1567-87, 2003.

J. Pritchard, M. Stephens, and P. Donnelly, Inference of population structure using multilocus genotype data, Genetics. Epub, vol.155, issue.206, pp.945-5903, 2000.

D. Adler, D. Murdoch, O. Nenadic, and S. Urbanek, rgl: 3D visualization device system (OpenGL). R package version 092, 2012.

J. González, L. Armengol, X. Solé, E. Guinó, J. Mercader et al., SNPassoc: an R package to perform whole genome association studies, Bioinformatics, vol.76, issue.5, pp.654-659, 2007.
DOI : 10.1086/429864

J. Goudet, hierfstat, a package for r to compute and test hierarchical F-statistics, Molecular Ecology Notes, vol.52, issue.3, pp.184-190, 2005.
DOI : 10.1111/j.1469-1809.1949.tb02451.x

D. Falush, M. Stephens, and J. Pritchard, Inference of population structure using multilocus genotype data: dominant markers and null alleles. Molecular ecology notes, Epub, vol.712, issue.4, pp.574-582, 2007.

G. Evanno, S. Regnaut, and J. Goudet, Detecting the number of clusters of individuals using the software structure: a simulation study, Molecular Ecology, vol.16, issue.8, pp.2611-2631, 2005.
DOI : 10.1098/rspb.2001.1600

M. Jakobsson and N. Rosenberg, CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure, Bioinformatics, vol.62, issue.5602, pp.1801-1807, 2007.
DOI : 10.1111/1467-9868.00265

N. Rosenberg, distruct: a program for the graphical display of population structure, Molecular Ecology Notes, vol.298, issue.1, pp.137-145, 2004.
DOI : 10.1046/j.1471-8286.2003.00566.x
URL : http://www.cmb.usc.edu/people/noahr/distructNote.pdf

C. Mizzi, E. Dalabira, J. Kumuthini, N. Dzimiri, I. Balogh et al., A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics, PLOS ONE, vol.92, issue.2, p.27636550, 2016.
DOI : 10.1371/journal.pone.0162866.s002
URL : https://doi.org/10.1371/journal.pone.0162866

V. Bonifaz-pena, A. Contreras, C. Struchiner, R. Roela, T. Furuya-mazzotti et al., Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations, PLoS ONE, vol.7, issue.12, p.112640, 2014.
DOI : 10.1371/journal.pone.0112640.s011

K. Fadhlaoui-zid, B. Martinez-cruz, H. Mendizabal, I. Benammar-elgaaied, A. Comas et al., Genetic structure of Tunisian ethnic groups revealed by paternal lineages, American Journal of Physical Anthropology, vol.74, issue.18, pp.271-80, 2011.
DOI : 10.1086/380911

R. Kefi, S. Hsouna, B. Halim, N. Lasram, K. Romdhane et al., Phylogeny and genetic structure of Tunisians and their position within Mediterranean populations, Mitochondrial DNA, vol.30, issue.4, pp.593-604, 2015.
DOI : 10.1002/(SICI)1520-6300(200005/06)12:3<339::AID-AJHB4>3.0.CO;2-U
URL : https://hal.archives-ouvertes.fr/pasteur-01060980

L. Cherni, A. Pakstis, S. Boussetta, S. Elkamel, S. Frigi et al., Genetic variation in Tunisia in the context of human diversity worldwide, American Journal of Physical Anthropology, vol.76, issue.1, pp.62-71, 2016.
DOI : 10.1086/428594

N. Limdi, M. Wadelius, L. Cavallari, N. Eriksson, D. Crawford et al., Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups, Blood, vol.115, issue.18, pp.3827-3861, 2009.
DOI : 10.1182/blood-2009-12-255992
URL : http://www.bloodjournal.org/content/bloodjournal/115/18/3827.full.pdf

T. Verhoef, G. Ragia, A. De-boer, R. Barallon, G. Kolovou et al., A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon, New England Journal of Medicine, vol.369, issue.24, pp.2304-2316, 2013.
DOI : 10.1056/NEJMoa1311388

S. Li, Y. Zou, X. Wang, X. Huang, Y. Sun et al., Warfarin Dosage Response Related Pharmacogenetics in Chinese Population, PLOS ONE, vol.348, issue.1, 2015.
DOI : 10.1371/journal.pone.0116463.t007
URL : https://doi.org/10.1371/journal.pone.0116463

P. Borst and R. Elferink, Mammalian ABC transporters in health and disease. Annual review of biochemistry, pp.537-92, 2002.
DOI : 10.1146/annurev.biochem.71.102301.093055
URL : https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf

J. Croop, P-glycoprotein structure and evolutionary homologies, Cytotechnology, vol.266, issue.Suppl, pp.1-3, 1993.
DOI : 10.1128/MCB.11.8.3940

J. Su, J. Xu, X. Li, H. Zhang, J. Hu et al., ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis, PLoS ONE, vol.7, issue.10, p.23056288, 2012.
DOI : 10.1371/journal.pone.0046366.s001
URL : https://doi.org/10.1371/journal.pone.0046366

M. Medina, F. Gao, W. Ruan, J. Rotter, and R. Krauss, Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin, Circulation, vol.118, issue.4, pp.355-62, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.773267
URL : http://circ.ahajournals.org/content/circulationaha/118/4/355.full.pdf

P. Kuehl, J. Zhang, Y. Lin, J. Lamba, M. Assem et al., Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, Nature Genetics, vol.10, issue.4, pp.383-91, 2001.
DOI : 10.1097/00008571-200006000-00001

M. Willrich, M. Hirata, F. Genvigir, S. Arazi, I. Rebecchi et al., CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia, Clinica chimica acta; international journal of clinical chemistry. Epub, vol.39830, issue.12, pp.15-20, 2008.
DOI : 10.1016/j.cca.2008.07.032

R. Wilke, J. Moore, and J. Burmester, Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage, Pharmacogenetics and Genomics, vol.15, issue.6, pp.415-2105, 2005.
DOI : 10.1097/01213011-200506000-00007

S. Lee, K. Usmani, B. Chanas, B. Ghanayem, T. Xi et al., Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups*, Pharmacogenetics, vol.13, issue.8, pp.461-72, 2003.
DOI : 10.1097/00008571-200308000-00004

K. Kurose, E. Sugiyama, and Y. Saito, Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development, Drug Metabolism and Pharmacokinetics, vol.27, issue.1, pp.9-54, 2011.
DOI : 10.2133/dmpk.DMPK-11-RV-111

R. Bains, M. Kovacevic, C. Plaster, A. Tarekegn, E. Bekele et al., Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa, BMC Genetics, vol.14, issue.1, pp.34-23641907, 2013.
DOI : 10.1086/378506
URL : https://bmcgenet.biomedcentral.com/track/pdf/10.1186/1471-2156-14-34?site=bmcgenet.biomedcentral.com

S. Humphries, D. Gable, J. Cooper, H. Ireland, J. Stephens et al., Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women, Journal of Molecular Medicine, vol.29, issue.S2, pp.1005-1019, 2006.
DOI : 10.1210/jc.2003-030453

E. Pearson, L. Donnelly, C. Kimber, A. Whitley, A. Doney et al., Influences Therapeutic Response to Sulfonylureas, Diabetes, vol.56, issue.8, pp.2178-82, 2007.
DOI : 10.2337/db07-0440
URL : http://diabetes.diabetesjournals.org/content/diabetes/56/8/2178.full.pdf

C. Pollastro, C. Ziviello, V. Costa, and A. Ciccodicola, Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?, PPAR Research, vol.18, issue.5, pp.415149-26161088, 2015.
DOI : 10.1126/science.1160342

S. Semiz, T. Dujic, B. Ostanek, B. Prnjavorac, T. Bego et al., Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus. Bosnian journal of basic medical sciences, pp.287-91, 2010.
DOI : 10.17305/bjbms.2010.2662
URL : http://europepmc.org/articles/pmc5489036?pdf=render

P. Guzzi, G. Agapito, D. Martino, M. Arbitrio, M. Tassone et al., DMET-Analyzer: automatic analysis of Affymetrix DMET Data, BMC Bioinformatics, vol.13, issue.1, pp.258-23035929, 2012.
DOI : 10.1186/1471-2105-11-315
URL : https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/1471-2105-13-258?site=bmcbioinformatics.biomedcentral.com

J. Burmester, M. Sedova, M. Shapero, and E. Mansfield, DMET??? Microarray Technology for Pharmacogenomics-Based Personalized Medicine, Methods in molecular biology, vol.632, pp.99-124, 2010.
DOI : 10.1007/978-1-60761-663-4_7

M. Arbitrio, D. Martino, M. Scionti, F. Agapito, G. Guzzi et al., DMET^TM (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine, Oncotarget, vol.7, issue.33, pp.54028-50, 2016.
DOI : 10.18632/oncotarget.9927
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9927&path%5B%5D=31178

L. Wang, Y. Ren, X. Shi, D. Yuan, K. Liu et al., The population genetics of pharmacogenomics VIP variants in the Sherpa population. Drug metabolism and pharmacokinetics, pp.82-91, 2016.

J. Pritchard, Are rare variants responsible for susceptibility to complex diseases? American journal of human genetics, Epub, vol.69, issue.106, pp.124-161, 2001.
DOI : 10.1086/321272
URL : https://doi.org/10.1086/321272

D. Mcalpine, J. Biernacka, D. Mrazek, O. Kane, D. Stevens et al., Effect of Cytochrome P450 Enzyme Polymorphisms on Pharmacokinetics of Venlafaxine, Therapeutic Drug Monitoring, vol.33, issue.1, pp.14-20, 2010.
DOI : 10.1097/FTD.0b013e3181fcf94d